citric acid, anhydrous has been researched along with Bacteremia in 10 studies
Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.
Bacteremia: The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurolidine-citrate use did not decrease all-cause bacteremia and was associated with a greater need for thrombolytic treatment." | 9.14 | A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. ( Al-Sayed, T; Bhat, R; Cheesbrough, JS; Curry, A; Diggle, P; Ebah, L; Heap, M; Millband, N; Mitra, S; Saxena, R; Schulz, M; Solomon, LR; Waterhouse, D, 2010) |
| "Preliminary evidence from some studies suggests that taurolidine-citrate locks decrease catheter-related bacteremia (CRB), which is a major cause of morbidity and mortality in patients using intravascular catheters." | 8.90 | Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. ( Chen, L; Deng, J; Liu, H; Wu, Y; Yuan, L, 2014) |
| "Taurolidine-citrate use did not decrease all-cause bacteremia and was associated with a greater need for thrombolytic treatment." | 5.14 | A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. ( Al-Sayed, T; Bhat, R; Cheesbrough, JS; Curry, A; Diggle, P; Ebah, L; Heap, M; Millband, N; Mitra, S; Saxena, R; Schulz, M; Solomon, LR; Waterhouse, D, 2010) |
| "Preliminary evidence from some studies suggests that taurolidine-citrate locks decrease catheter-related bacteremia (CRB), which is a major cause of morbidity and mortality in patients using intravascular catheters." | 4.90 | Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis. ( Chen, L; Deng, J; Liu, H; Wu, Y; Yuan, L, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hemmelgarn, BR | 1 |
| Manns, BJ | 1 |
| Soroka, SD | 1 |
| Levin, A | 1 |
| MacRae, J | 1 |
| Tennankore, K | 1 |
| Wilson, JS | 1 |
| Weaver, RG | 1 |
| Ravani, P | 1 |
| Quinn, RR | 1 |
| Tonelli, M | 1 |
| Kiaii, M | 1 |
| Mossop, P | 1 |
| Scott-Douglas, N | 1 |
| Clark, JE | 1 |
| Graham, N | 1 |
| Kleidon, T | 1 |
| Ullman, A | 1 |
| Chong, CY | 1 |
| Ong, RY | 1 |
| Seah, VX | 1 |
| Tan, NW | 1 |
| Chan, MY | 1 |
| Soh, SY | 1 |
| Ong, C | 1 |
| Lim, AS | 1 |
| Thoon, KC | 1 |
| Niyyar, VD | 1 |
| Lok, CE | 1 |
| Liu, H | 2 |
| Deng, J | 1 |
| Chen, L | 1 |
| Yuan, L | 1 |
| Wu, Y | 1 |
| Murray, EC | 1 |
| Deighan, C | 1 |
| Geddes, C | 1 |
| Thomson, PC | 1 |
| Raad, II | 1 |
| Fang, X | 1 |
| Keutgen, XM | 1 |
| Jiang, Y | 1 |
| Sherertz, R | 1 |
| Hachem, R | 1 |
| Steczko, J | 1 |
| Ash, SR | 1 |
| Nivens, DE | 1 |
| Brewer, L | 1 |
| Winger, RK | 1 |
| Solomon, LR | 1 |
| Cheesbrough, JS | 1 |
| Ebah, L | 1 |
| Al-Sayed, T | 1 |
| Heap, M | 1 |
| Millband, N | 1 |
| Waterhouse, D | 1 |
| Mitra, S | 1 |
| Curry, A | 1 |
| Saxena, R | 1 |
| Bhat, R | 1 |
| Schulz, M | 1 |
| Diggle, P | 1 |
| Boszczowski, I | 1 |
| Nóbrega de Almeida Júnior, J | 1 |
| Peixoto de Miranda, EJ | 1 |
| Pinheiro Freire, M | 1 |
| Guimarães, T | 1 |
| Chaves, CE | 1 |
| Cais, DP | 1 |
| Strabelli, TM | 1 |
| Risek, CF | 1 |
| Soares, RE | 1 |
| Rossi, F | 1 |
| Costa, SF | 1 |
| Levin, AS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Pilot Study to Evaluate the Effect of Livionex on Reducing Plaque Accumulation and Improving Oral Health in Children[NCT04368533] | 78 participants (Actual) | Interventional | 2019-02-08 | Completed | |||
| Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non[NCT02279121] | 162 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for citric acid, anhydrous and Bacteremia
| Article | Year |
|---|---|
Pros and cons of catheter lock solutions.
Topics: Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Cit | 2013 |
Preventing catheter-related bacteremia with taurolidine-citrate catheter locks: a systematic review and meta-analysis.
Topics: Anti-Infective Agents; Anticoagulants; Bacteremia; Citric Acid; Female; Humans; Male; PubMed; Taurin | 2014 |
The role of chelators in preventing biofilm formation and catheter-related bloodstream infections.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Adhesion; Biofilms; Catheterization; Chelating Agents; | 2008 |
2 trials available for citric acid, anhydrous and Bacteremia
| Article | Year |
|---|---|
Taurolidine-citrate lock solution for the prevention of central line-associated bloodstream infection in paediatric haematology-oncology and gastrointestinal failure patients with high baseline central-line associated bloodstream infection rates.
Topics: Adolescent; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Central Venous | 2020 |
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Topics: Adult; Aged; Anti-Infective Agents; Anticoagulants; Bacteremia; Catheters, Indwelling; Citric Acid; | 2010 |
5 other studies available for citric acid, anhydrous and Bacteremia
| Article | Year |
|---|---|
Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.
Topics: Aged; Aged, 80 and over; Anticoagulants; Bacteremia; Catheter Obstruction; Catheter-Related Infectio | 2018 |
Taurolidine-Citrate Line Locks Prevent Recurrent Central Line-Associated Bloodstream Infection in Pediatric Patients.
Topics: Adolescent; Anti-Infective Agents, Local; Bacteremia; Catheter-Related Infections; Catheterization, | 2019 |
Taurolidine-citrate-heparin catheter lock solution reduces staphylococcal bacteraemia rates in haemodialysis patients.
Topics: Anti-Infective Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwe | 2014 |
Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens).
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Biofilms; Catheter-Related Infections; Catheterization, | 2009 |
Nosocomial outbreak of Pantoea agglomerans bacteraemia associated with contaminated anticoagulant citrate dextrose solution: new name, old bug?
Topics: Aged; Aged, 80 and over; Bacteremia; Bacterial Typing Techniques; Citric Acid; Cross Infection; Dise | 2012 |